Silverback Therapeutics Inc (SBTX)

NASDAQ
7.19
-0.11(-1.51%)
After Hours
7.19
0.00(0.00%)
- Real-time Data
  • Volume:
    177,304
  • Bid/Ask:
    6.85/7.27
  • Day's Range:
    6.96 - 7.36

SBTX Overview

Prev. Close
7.3
Day's Range
6.96-7.36
Revenue
-
Open
7.1
52 wk Range
6.94-63.41
EPS
-2.22
Volume
177,304
Market Cap
251.92M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
509,607
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
35,037,136
Next Earnings Date
27 Mar 2022
What is your sentiment on Silverback Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Silverback Therapeutics Inc Company Profile

Employees
83

Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Its lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. The company also focuses on developing SBT6290, a product candidate that is in preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple negative breast, head and neck, and non-small cell lung cancers. In addition, it engages in developing SBT8230, a TLR8 linker-payload conjugated to an ASGR1 monoclonal antibody that is under development for the treatment of chronic hepatitis B virus infection; and agents that localize therapies to modulate pathways in additional oncology and fibrosis indications using TLR8 and other linker-payloads. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralSellStrong SellSell
Technical IndicatorsNeutralStrong BuySellStrong SellSell
SummaryNeutralBuySellStrong SellSell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.